Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiqing Yuan

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Plos One|January 25, 2021
Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoproteinChuancai Sun, Jian Zhang, Jiao Wei, et al.
European Journal of Cell Biology|June 19, 2014
Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cellsDenglu Zhang, Yazhou Cui, Leilei Niu, et al.
Pharmaceutical Biology|May 29, 2015
Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cellsZhongyi Hu, Denglu Zhang, Dawei Wang, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2025
Prognosis and predictive factors in pediatric IgA nephropathyWenpei Liang, Yonghua He, Xueqing Ma, et al.
Cancer Letters|May 23, 2013
Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cellsYongqing Liu, Fengbin Gao, Hanming Jiang, et al.
Oncogene|January 17, 2019
Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumabDawei Wang, Qingqing Xu, Quan Yuan, et al.
Plos One|September 27, 2013
Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In VivoZhongyi Hu, Feng Kong, Manfei Si, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Imaging genomics for accurate diagnosis and treatment of tumors: A cutting edge overviewZhen Liu, Kefeng Wu, Binhua Wu, et al.
BMC Nephrology|August 27, 2025
Pathogenic synonymous variation of the COL4A3 gene causing Alport syndrome comorbid with IgA deposition in a toddler: a case reportPanpan Shao, Wenpei Liang, Rongrong Xv, et al.
Nanoscale Advances|September 22, 2022
Self-assembled anionic and cationic Au nanoparticles with Au nanoclusters for the exploration of different biological responsiveness in cancer therapyJingjing Yang, Lu Zhang, Qian Zhou, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Plos One|January 25, 2021
Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoproteinChuancai Sun, Jian Zhang, Jiao Wei, et al.
European Journal of Cell Biology|June 19, 2014
Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cellsDenglu Zhang, Yazhou Cui, Leilei Niu, et al.
Pharmaceutical Biology|May 29, 2015
Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cellsZhongyi Hu, Denglu Zhang, Dawei Wang, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2025
Prognosis and predictive factors in pediatric IgA nephropathyWenpei Liang, Yonghua He, Xueqing Ma, et al.
Cancer Letters|May 23, 2013
Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cellsYongqing Liu, Fengbin Gao, Hanming Jiang, et al.
Oncogene|January 17, 2019
Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumabDawei Wang, Qingqing Xu, Quan Yuan, et al.
Plos One|September 27, 2013
Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In VivoZhongyi Hu, Feng Kong, Manfei Si, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Imaging genomics for accurate diagnosis and treatment of tumors: A cutting edge overviewZhen Liu, Kefeng Wu, Binhua Wu, et al.
BMC Nephrology|August 27, 2025
Pathogenic synonymous variation of the COL4A3 gene causing Alport syndrome comorbid with IgA deposition in a toddler: a case reportPanpan Shao, Wenpei Liang, Rongrong Xv, et al.
Nanoscale Advances|September 22, 2022
Self-assembled anionic and cationic Au nanoparticles with Au nanoclusters for the exploration of different biological responsiveness in cancer therapyJingjing Yang, Lu Zhang, Qian Zhou, et al.
Pageof 10